Open help menu
On-Demand

Kratom Today: Toxicology, Emerging Preparations, and Clinical Implications

Suman Rana, MSc, PhD, MBA
|

Information

Recorded

  • -

Description

Join Dr. Suman Rana, Chief Toxicology Advisor at Lynk Diagnostics and founder of THINKTOX, for a toxicology-focused overview of kratom and its increasingly potent formulations, designed for clinicians and behavioral health professionals. Topics will include pharmacology and metabolism, differences between traditional plant products and concentrated or synthetic formulations, patterns of use, adverse effects, drug–drug interactions, and implications for impairment, dependence, and withdrawal. The session will also address current regulatory gaps and practical considerations for patient assessment, counseling, and risk management in clinical and behavioral health settings.

Educational Goal

The educational goal of this workshop is to improve clinician and behavioral health professional understanding of kratom and its newer preparations by providing a toxicology-based framework to recognize prevalence, assess risk, and support informed clinical and patient counseling decisions.

Learning Objectives

Participants will be able to:

  • Describe the pharmacology and toxicology of kratom and its newer preparations

  • Recognize the growing prevalence of kratom use and associated public health concerns

  • Identify two to three key adverse effects, including toxicity, dependence, withdrawal, and impairment risk

  • Apply toxicology principles to clinical and behavioral health assessment and patient counseling

Target Audience

  • Addiction Professional
  • Counselor
  • Marriage & Family Therapist
  • Physician
  • Psychologist
  • Social Worker

Presenters

Suman Rana, MSc, PhD, MBA
Dr. Suman Rana is the Founder and Chief Toxicologist of THINKTOX, providing consulting and advisory services to industry, government, and legal sectors. She serves on the Advisory Board of Impairment Science Inc. and Lynk Diagnostics. She is an advocate for evidence-based approaches to drug policy and workplace safety. She has over 25 years of exceptional technical and leadership experience in the field of toxicology. Her career encompasses roles as a seasoned researcher, scientific and operations director, showcasing a remarkable journey of innovation and impactful leadership at Fortune 100 companies, such as Abbott. Dr. Rana is a past president of the Society of Forensic Toxicologists (SOFT). She is an avid supporter of establishing industry standards for the field of toxicology and serves on the Consensus Body of the Academy Standards Board (ASB), where she helps elevate the field by contributing to critical review and revision of the toxicology consensus standards Dr. Rana's commitment to advancing the field of toxicology is evident from her volunteer work with several scientific organizations. She serves on the Alcohol, Drugs, and Impairment Division (ADID) of the National Safety Council (NSC). She is a member of the joint Oral Fluid Committee of SOFT and the American Academy of Forensic Sciences (AAFS). She has contributed to over 100 scientific abstracts, papers, and workshop lectures and serves on the Editorial Board of the Journal of Analytical Toxicology (JAT). Recognized internationally as a thought leader, she has been an invited speaker on numerous occasions and has facilitated technical workshops and training sessions. A Fellow with the American Academy of Forensic Sciences (AAFS), Dr. Rana is a member of the International Association of Chemical Testing (IACT) and the International Association of Forensic Toxicologists (TIAFT), where she serves as the Regional Representative for the United States.

Financially Sponsored By

  • Lynk Diagnostics